NV-A01

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameNV-A01
Drug Alias Namerecombinant adenovirus (Nanjing Novi Biotechnology)
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursGlioblastomaGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNanjing Noling Biotechnology Co., Ltd.
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Noling Biotechnology Co., Ltd.
Inactive CompaniesN/A
Active IndicationsSolid tumoursGlioblastomaGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A